pocketful logo
Alembic Pharmaceuticals Ltd logo

Alembic Pharmaceuticals Ltd

NSE: APLLTD BSE: 533573

₹677.30

(3.33%)

Tue, 31 Mar 2026, 04:53 am

Alembic Pharmaceuticals Debt to Equity Ratio

Particulars2009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio007.0111.8822.7330.2015.7329.1625.1217.1212.1416.3127.9728.5131.3631.31
Price to book ratio002.313.907.929.667.096.184.673.673.093.782.792.224.013.52
Price to sales ratio000.631.312.934.233.693.853.392.602.233.542.771.753.152.79
Price to cash flow ratio008.447.7223.6750.6011.9836.2236.0213.4029.6013.4328.8514.4425.491230
Enterprise value0012.19B21.34B54.36B87.81B109.85B116.86B109.83B109.24B117.81B189.9B152.2B103.88B196.96B194.32B
Enterprise value to EBITDA ratio006.159.5816.8524.4311.5120.4319.6613.959.9713.6517.7315.6523.2121.49
Debt to equity ratio01.110.900.370.160.300.070.050.320.410.560.120.140.160.110.24
Return on equity %0037.6336.8139.9736.2758.0223.0420.0223.6427.7227.7010.177.1213.3811.66

Alembic Pharmaceuticals Ltd Debt to Equity Ratio

The Alembic Pharmaceuticals Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Alembic Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Alembic Pharmaceuticals Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Alembic Pharmaceuticals Ltd (NSE: APLLTD, BSE: 533573) is currently trading at ₹677.30, with a market capitalization of ₹133.08B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Alembic Pharmaceuticals Ltd Debt to Equity Ratio is essential for fundamental analysis.

Alembic Pharmaceuticals Ltd Debt to Equity Ratio Current Value

The current Alembic Pharmaceuticals Ltd Debt to Equity Ratio stands at 0.24.

The latest Alembic Pharmaceuticals Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Alembic Pharmaceuticals Ltd Debt to Equity Ratio Historical Trend

The Alembic Pharmaceuticals Ltd Debt to Equity Ratio has shown the following historical trend:

  • 2024: 0.24
  • 2023: 0.11
  • 2022: 0.16
  • 2021: 0.14
  • 2020: 0.12

The recent rise in Alembic Pharmaceuticals Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.

What Alembic Pharmaceuticals Ltd Debt to Equity Ratio Indicates for Investors

The Alembic Pharmaceuticals Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.

The D/E ratio measures financial leverage and balance sheet strength.

Alembic Pharmaceuticals Ltd Debt to Equity Ratio Analysis Summary

The Alembic Pharmaceuticals Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alembic Pharmaceuticals Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Alembic Pharmaceuticals Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800